SCHEMBL1641950

SCHEMBL1641950

CN(C)C1Cc2ccc(Nc3nccc(-c4scnc4-c4cccc(NC(=O)Cc5cccs5)c4)n3)cc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 2/20 0.46
▸ IGF1R P08069 11/20 0.46
▸ EGFR P00533 10/20 0.46
▸ ERBB2 P04626 9/20 0.46
▸ PTK2 Q05397 2/20 0.44
▸ CDK19 Q9BWU1 1/20 0.44
▸ RET P07949 4/20 0.42
▸ KDR P35968 4/20 0.42
▸ STK3 Q13188 4/20 0.42
▸ MAP4K5 Q9Y4K4 4/20 0.42
▸ AURKA O14965 3/20 0.42
▸ PRKD3 O94806 3/20 0.42
▸ MAP4K4 O95819 3/20 0.42
▸ INSR P06213 3/20 0.42
▸ LCK P06239 3/20 0.42
▸ FYN P06241 3/20 0.42
▸ LYN P07948 3/20 0.42
▸ FGFR1 P11362 3/20 0.42
▸ FLT4 P35916 3/20 0.42
▸ FRK P42685 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1790063 0.85 IGF1R (0.54) IGF1REGFRERBB2PTK2CDK19
SCHEMBL12726553 0.85 IGF1R (0.54) IKBKBIGF1REGFRERBB2PTK2
SCHEMBL3541687 0.84 KDR (0.53) IKBKBIGF1REGFRERBB2PTK2
SCHEMBL1640319 0.82 IGF1R (0.49) IKBKBIGF1REGFRERBB2PTK2
SCHEMBL1641894 0.81 IGF1R (0.47) IKBKBIGF1REGFRERBB2PTK2
SCHEMBL1641750 0.80 IGF1R (0.51) IKBKBIGF1REGFRERBB2PTK2
SCHEMBL1641883 0.80 AGER (0.45) IKBKBIGF1REGFRERBB2PTK2
SCHEMBL12766967 0.79 IKBKB (0.46) IKBKBIGF1REGFRERBB2PTK2
SCHEMBL12726554 0.79 IKBKB (0.46) IKBKBIGF1REGFRERBB2PTK2
Hydrochloric Acid SCHEMBL1641781 0.78 IKBKB (0.45) IKBKBIGF1REGFRERBB2PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-04-28 — — US disclosed
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-04-28 — — US disclosed
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-04-28 — — US disclosed
WO-2009076140-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors PDXK, MAP3K1, MAP4K2 IKBKB 471/4885IGF1R 396/4885EGFR 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback